Effects of hepatic impairment on the steady-state pharmacokinetics of etravirine 200 mg BID: an open-label, multiple-dose, controlled Phase I study in adults (Q43141111)
Jump to navigation
Jump to search
scientific article published in February 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Effects of hepatic impairment on the steady-state pharmacokinetics of etravirine 200 mg BID: an open-label, multiple-dose, controlled Phase I study in adults |
scientific article published in February 2010 |
Statements
1 reference
Effects of hepatic impairment on the steady-state pharmacokinetics of etravirine 200 mg BID: an open-label, multiple-dose, controlled Phase I study in adults (English)
1 reference
Monika Schöller-Gyüre
1 reference
Thomas N Kakuda
1 reference
Goedele De Smedt
1 reference
Brian Woodfall
1 reference
Cindy Berckmans
1 reference
Monika Peeters
1 reference
Richard M W Hoetelmans
1 reference
1 February 2010
1 reference
1 reference
32
1 reference
2
1 reference
328-337
1 reference
Identifiers
1 reference
1 reference